Fertility and Sterility
Volume 78, Issue 5 , Pages 961-972 , November 2002

Consensus statement for the management of chronic pelvic pain and endometriosis: proceedings of an expert-panel consensus process

  • Joseph C Gambone (D.O., M.P.H.)

      Affiliations

    • David Geffen School of Medicine at UCLA, Los Angeles, California, USA
    • Department of Veterans Affairs, Greater Los Angeles Healthcare System, Los Angeles, California, USA
    • Corresponding Author InformationCorresponding author: Joseph C. Gambone, D.O., M.P.H., Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, Los Angeles, California 90095-1740 (FAX: 310-206-3670), USA
    • ,
  • Brian S Mittman, Ph.D.

      Affiliations

    • Department of Veterans Affairs, Greater Los Angeles Healthcare System, Los Angeles, California, USA
    • RAND Health, Santa Monica, California, USA
    • ,
  • Malcolm G Munro, M.D.

      Affiliations

    • David Geffen School of Medicine at UCLA, Los Angeles, California, USA
    • ,
  • Anthony R Scialli, M.D.

      Affiliations

    • Georgetown University School of Medicine, Washington, D.C., USA
    • ,
  • Craig A Winkel, M.D., M.B.A.

      Affiliations

    • Georgetown University School of Medicine, Washington, D.C., USA
    • ,
  • the Chronic Pelvic Pain/Endometriosis Working Group

Received 2 April 2002 ,Revised 11 July 2002 ,Accepted 11 July 2002.

References 

  1. Reiter RC. A profile of women with chronic pelvic pain. Clin Obstet Gynecol. 1990;33:130–136
  2. Gambone JC, Reiter RC, Slesinski MJ, Reiter RC, Moore JG. Validation of hysterectomy indications and the quality assurance process. Obstet Gynecol. 1989;73:1045–1049
  3. Koninckx PR, Meuleman C, Demeyere S, Lesaffre E, Cornillie FJ. Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain. Fertil Steril. 1991;55:759–765
  4. Carter JE. Combined hysteroscopic and laparoscopic findings in patients with chronic pelvic pain. J Am Assoc Gynecol Laparosc. 1994;2:43–47
  5. Ling F  Pelvic Pain Study Group . Randomized controlled trial of depot leuprolide in patients with chronic pelvic pain and clinically suspected endometriosis. Obstet Gynecol. 1999;93:51–58
  6. Wardle P, Hull MGR. Is endometriosis a disease?. Bailleres Clin Obstet Gynaecol. 1993;7:673–685
  7. Thomas EJ. Endometriosis, 1995—confusion or sense?. Int J Obstet Gynecol. 1995;48:149–155
  8. American Medical Association, Office of Quality Assurance . Attributes to guide the development and evaluation of practice parameters. Chicago, IL: American Medical Association; 1990;
  9. Woolf SH. Manual for clinical practice guideline development. Rockville, MD: Agency for Health Care Policy and Research; 1991; AHCPR publication 91-0007
  10. Grimshaw JM, Freemantle N, Wallace S. Developing and implementing clinical practice guidelines. Qual Health Care. 1995;4:55–64
  11. Hamann GO. Severe primary dysmenorrhea treated with naproxen. A prospective, double-blind crossover investigation. Prostaglandins. 1980;19:651–657
  12. Hanson FW, Izu A, Henzl MR. Naproxen sodium, ibuprofen and a placebo in dysmenorrhea. Its influence in allowing continuation of work/school activities. Obstet Gynecol. 1978;52:583–587
  13. Henzl MR, Buttram V, Segre EJ, Bessler S. The treatment of dysmenorrhea with naproxen sodium (a report on two independent double-blind trials). Am J Obstet Gynecol. 1977;127:818–823
  14. Roy S. A double-blind comparison of a propionic acid derivative (ibuprofen) and a fenamate (mefenamic acid) in the treatment of dysmenorrhea. Obstet Gynecol. 1983;61:628–632
  15. Jacobsen J. Naproxen in the treatment of OC-resistant primary dysmenorrhea. A double-blind cross-over study. Acta Obstet Gynecol Scand. 1983;113(Suppl):87–89
  16. Arnold JD. Comparison of fenoprofen calcium, ibuprofen and placebo in primary dysmenorrhea. J Reprod Med. 1983;14:337–350
  17. Kistner RW. Treatment of endometriosis by inducing pseudo-pregnancy with ovarian hormones. Fertil Steril. 1959;10:539–554
  18. Robinson JL. Dysmenorrhea and use of oral contraceptives in adolescent women attending a family planning clinic. Am J Obstet Gynecol. 1992;166:578–583
  19. Milsom I, Sundell G, Andersch B. The influence of different combined oral contraceptives on the prevalence and severity of dysmenorrhea. Contraception. 1990;42:497–506
  20. Milsom I, Andersch B. Effect of various oral contraceptives combinations on dysmenorrhea. Gynecol Obstet Invest. 1984;17:284–292
  21. Vercellini P, Trespidi L, Colombo A, Vendola N, Marchini M, Crosignani PG. A gonadotrophin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis. Fertil Steril. 1993;60:75–79
  22. Barbieri RL. Endometriosis 1990—current treatment approaches. Drugs. 1990;39:502–510
  23. Kauppila A, Telimaa S, Ronnberg L, Vuori J. Placebo-controlled study on serum concentrations of CA-125 before and after treatment of endometriosis with danazol or high-dose medroxyprogesterone acetate alone or after surgery. Fertil Steril. 1988;49:37–41
  24. Telimaa S, Puolakka J, Ronnberg L, Kauppila A. Placebo-controlled comparison of danazol and medroxyprogesterone acetate in the treatment of endometriosis. Gynecol Endocrinol. 1987;1:13–23
  25. Telimaa S, Apter D, Reinila M, Ronnberg L, Kauppila A. Placebo-controlled comparison of hormonal and biochemical effects of danazol and high-dose medroxyprogesterone acetate. Eur J Obstet Gynaecol Reprod Biol. 1990;36:97–105
  26. Telimaa S, Ronnberg L, Kauppila A. Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis after conservative surgery. Gynecol Endocrinol. 1987;1:363–371
  27. Dlugi AM, Miller JD, Knittle J. Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis (a randomized, placebo-controlled, double-blind study. Lupron Study Group). Fertil Steril. 1990;54:419–427
  28. Anonymous . Goserelin depot versus danazol in the treatment of endometriosis. The Australian/New Zealand experience. Aust NZ J Obstet Gynaecol. 1996;31:55–60
  29. Chang SP, Ng HT. A randomized comparative study of the effect of leuprorelin acetate depot and danazol in the treatment of endometriosis. Chin Med J (Taipei). 1996;57:431–437
  30. Cirkel U, Ochs H, Schneider HPG. A randomized, comparative trial of triptorelin depot (D-Trp6-LHRH) and danazol in the treatment of endometriosis. Eur J Obstet Gynecol Reprod Biol. 1995;59:61–69
  31. Crosignani PG, Gastaldi A, Lombardi PL. Leuprorelin acetate depot vs danazol in the treatment of endometriosis (results of an open multicentre trial). Clin Ther. 1992;14(Suppl A):29–36
  32. Dmowski WP, Radwanska E, Binor Z, Tummon I, Pepping P. Ovarian suppression induced with Buserelin or danazol in the management of endometriosis (a randomized, comparative study). Fertil Steril. 1989;51:395–400
  33. Fraser IS, Shearman RP, Jansen RP, Sutherland PD. A comparative treatment trial of endometriosis using the gonadotrophin-releasing hormone agonist, nafarelin, and the synthetic steroid, danazol. Aust NZ J Obstet Gynaecol. 1991;31:158–163
  34. Henzl MR, Corson SL, Moghissi K, Buttram VC, Berqvist C, Jacobson J. Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial. N Engl J Med. 1988;318:485–489
  35. Adamson GD, Kwei L, Edgren RA. Pain of endometriosis (effects of nafarelin and danazol therapy). Int J Fertil Menopausal Stud. 1994;39:215–217
  36. Wheeler JM, Knittle JD, Miller JD. Depot leuprolide versus danazol in treatment of women with symptomatic endometriosis. I. Efficacy results. Am J Obstet Gynecol. 1992;167:1367–1371
  37. Dawood MY, Ramos J, Khan-Dawood FS. Depot leuprolide acetate versus danazol for treatment of pelvic endometriosis (changes in vertebral bone mass and serum estradiol and calcitonin). Fertil Steril. 1995;63:1177–1183
  38. Nafarelin European Endometriosis Trial Group (NEET) . Nafarelin for endometriosis (a large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up). Fertil Steril. 1992;57:514–522
  39. Rolland R, van der Heijden PF. Nafarelin versus danazol in the treatment of endometriosis. Am J Obstet Gynecol. 1990;162:586–588
  40. Kennedy SH, Williams IA, Brodribb J, Barlow DH, Shaw RW. A comparison of nafarelin acetate and danazol in the treatment of endometriosis. Fertil Steril. 1990;53:998–1003
  41. Rock JA. A multicenter comparison of GnRH agonist (Zoladex) and danazol in the treatment of endometriosis. Fertil Steril. 1991;56:S49
  42. Shaw RW. An open randomized comparative study of the effect of goserelin depot and danazol in the treatment of endometriosis. Zoladex Endometriosis Study Team. Fertil Steril. 1992;58:265–272
  43. Surrey E, Judd H. Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis (a prospective randomized trial). J Clin Endocrinol Metab. 1992;75:558–563
  44. Makarainen L, Ronneberg L, Kauppila A. Medroxyprogesterone acetate supplementation diminishes the hypoestrogenic side-effects of gonadotropin-releasing hormone agonists without changing its efficacy in endometriosis. Fertil Steril. 1996;65:29–34
  45. Tabkin O, Yakinoghe AH, Kucuk S, Uryan I, Buhur A, Burak F. Effectiveness of tibolone on hypoestrogenic symptoms induced by goserelin treatment in patients with endometriosis. Fertil Steril. 1997;67:40–45
  46. Edmonds D, Howell R. Can hormone replacement therapy be used during medical therapy of endometriosis?. Br J Obstet Gynecol. 1994;101:24–26
  47. Kiiholma P, Korhonen M, Tuimala R, Korhonen M, Hagman E. Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosis. Fertil Steril. 1995;64:903–908
  48. Moghissi KS, Schlaff WD, Olive DL, Skinner MA, Yin H. Goserelin acetate (Zoladex) with or without hormone replacement therapy for the treatment of endometriosis. Fertil Steril. 1998;69:1056–1062
  49. Surrey ES, Voigt B, Fournet N, Judd HL. Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis (the role of cyclic sodium etidronate and low dose norethindrone “add-back” therapy). Fertil Steril. 1995;63:747–755
  50. Hornstein MD, Surrey ES, Weisberg GW, Casino LA  Lupron Add-Back Study Group . Leuprolide acetate depot and hormonal add-back in endometriosis (a 12-month study). Obstet Gynecol. 1998;91:16–24
  51. Henzl MR, Kwei L. Efficacy and safety of nafarelin in the treatment of endometriosis. Am J Obstet Gynecol. 1990;162:570–574
  52. Vercellini P, Cortesi I, Crosignani P. Progestins for symptomatic endometriosis (a critical analysis of the evidence). Fertil Steril. 1997;68:393–401
  53. Fedele L, Arcaini L, Bianchi S, Baglioni A, Vercillini P. Comparison of cyproterone acetate and danazol in the treatment of pelvic pain associated with endometriosis. Obstet Gynaecol. 1989;73:1000–1004
  54. Vercellini P, De Giorgi O, Oldani S, Cortesi I, Panazza S, Crosignani PG. Depot medroxyprogesterone acetate versus an oral contraceptive combined with very low dose danazol for long term treatment of pelvic pain associated with endometriosis. Am J Obstet Gynecol. 1996;175:396–401
  55. Overton C, Lindsay P, Johal B, Collins S, Siddle N, Shaw R, et al.  A randomized, double-blind, placebo-controlled study of luteal phase dydrogesterone (Duphaston) in women with minimal to mild endometriosis. Fertil Steril. 1985;43:351–352
  56. Vercellini P, Trespidi L, Colombo A, Vendola N, Marchini M, Crosignani PG. A gonadotropin releasing hormone agonist vs low dose oral contraceptive for pelvic pain associated with endometriosis. Fertil Steril. 1993;60:75–79
  57. Fedele L, Arcaini L, Bianchi S, Baglioni A, Vercellini P. Comparison of cyproterone acetate and danazol in the treatment of pelvic pain associated with endometriosis. Obstet Gynecol. 1989;73:1000–1004
  58. Walton SM, Batra HK. The use of medroxyprogesterone acetate 50 mg in the treatment of painful pelvic conditions (preliminary results from a multicenter trial). J Obstet Gynaecol. 1992;12(Suppl 2):S50–S53
  59. Adamson GD, Nelson HP. Surgical treatment of endometriosis. Obstet Gynecol Clin North Am. 1997;24:375–408
  60. Telimaa S, Ronnberg L, Kauppila A. Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis after conservative surgery. Gynecol Endocrinol. 1987;1:363–371
  61. Bianchi S, Busacca M, Agnoli B, Candiani M, Calia C, Vignali M. Effects of 3 month therapy with danazol after laparoscopic surgery for stage III/IV endometriosis (a randomized study). Hum Reprod. 1999;14:1335–1337
  62. Morgante G, Ditto A, La Marca A, De Leo V. Low-dose danazol after combined surgical and medical therapy reduces the incidence of pelvic pain in women with moderate and severe endometriosis. Hum Reprod. 1999;14:2371–2374
  63. Parazzini F, Fedele L, Busacca M, Falsetti L, Pellegrini S, Venturini PL, et al.  Postsurgical medical treatment of advanced endometriosis (results of a randomized clinical trial). Am J Obstet Gynecol. 1994;171:1205–1207
  64. Vercellini P, Crosignani PG, Fadini R, Radici E, Belloni C, Sismondi P. A gonadotrophin-releasing hormone agonist compared with expectant management after conservative surgery for symptomatic endometriosis. Br J Obstet Gynaecol. 1999;106:672–677
  65. Hornstein MD, Hemmings R, Yuzpe AA, Heinrichs WL. Use of nafarelin versus placebo after reductive laparoscopic surgery for endometriosis. Fertil Steril. 1997;68:860–864
  66. Winkel CA, Bray M, eds. Treatment of women with endometriosis using excision alone, ablation alone, or ablation in combination with leuprolide acetate [abstract no. 105]. Proceedings of the 5th World Congress on Endometriosis, Oct. 21–24, 1996, Pacifico, Yokohama, Japan; 1996:55.
  67. Sutton CJG, Ewen SP, Whitelaw N, Haines P. Prospective, randomized, double-blind, controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal, mild, and moderate endometriosis. Fertil Steril. 1994;62:696–700
  68. Redwine DB. Conservative laparoscopic excision of endometriosis by sharp dissection (life table analysis of reoperation and persistent or recurrent disease). Fertil Steril. 1991;56:628–634
  69. Sutton C, Pooley AS, Jones KD, Dover RW, Haines P. A prospective, randomized, double-blind controlled trial of laparoscopic uterine nerve ablation in the treatment of pelvic pain associated with endometriosis. Gynecol Endosc. 2001;10:217–222
  70. Fayez JA, Vogel MF. Comparison of different treatment methods of endometriomas by laparoscopy. Obstet Gynecol. 1991;78:660–665
  71. Saleh A, Tulandi T. Reoperation after laparoscopic treatment of ovarian endometriomas by excision and by fenestration. Fertil Steril. 1999;72:322–324
  72. Beretta P, Franchi M, Ghezzi F, Busacca M, Zupi E, Bolis P. Randomized clinical trial of two laparoscopic treatments of endometriomas (cystectomy versus drainage and coagulation). Fertil Steril. 1998;70:1176–1180
  73. Crosignani PG, Vercellini P, Biffignandi F, Costantini W, Cortesi I, Imparato E. Laparoscopy versus laparotomy in conservative surgical treatment for severe endometriosis. Fertil Steril. 1996;66:706–711
  74. Busacca M, Fedele L, Bianchi S, Candiani M, Agnoli B, Raffaelli R, et al.  Surgical treatment of recurrent endometriosis (laparotomy versus laparoscopy). Hum Reprod. 1998;13:2271–2274
  75. Catalano GF, Marana R, Caruana P, Muzii L, Mancusco S. Laparoscopy versus microsurgery by laparotomy for excision of ovarian cysts in patients with moderate or severe endometriosis. J Am Assoc Gynecol Laparosc. 1996;3:267–270
  76. Bateman BG, Kolp LA, Mills S. Endoscopy versus laparotomy management of endometriomas. Fertil Steril. 1994;62:690–695
  77. Lichten EM, Bombard J. Surgical treatment of primary dysmenorrhea with laparoscopic uterine nerve ablation. J Reprod Med. 1987;32:37–41
  78. Candiani GB, Fedele L, Vercellini P, Bianch S, Di Nola G. Presacral neurectomy for the treatment of pelvic pain associated with endometriosis (a controlled study). Am J Obstet Gynecol. 1992;167(1):100–103
  79. Tjaden B, Schlaff WD, Kimball A, Rock JA. The efficacy of presacral neurectomy for the relief of midline dysmenorrhea. Obstet Gynecol. 1990;76:89–91
  80. Chen FP, Chang SD, Chu K, Soong YK. Comparison of laparoscopic presacral neurectomy and laparoscopic uterine nerve ablation for primary dysmenorrhea. J Reprod Med. 1996;41:463–466
  81. Namnoum AB, Hickman TN, Goodman AB, Gehlbach DL, Rock JA. Incidence of symptom recurrence after hysterectomy for endometriosis. Fertil Steril. 1995;64:898–902
  82. Chassin MR, Brook RH, Park RE, Keesey J, Fink A, Kosecoff J, et al.  Variations in the use of medical and surgical services by the Medicare population. N Engl J Med. 1986;314:285–290
  83. Cook DJ, Mulrow CD, Haynes RB. Systematic reviews (synthesis of best evidence for clinical practice). Ann Intern Med. 1997;126:376–380
  84. Leape LL, Park RE, Kahan JP, Brook RH. Group judgments of appropriateness (the effect of panel composition). Qual Assur Health Care. 1992;4:151–159
  85. Reiter RC, Gambone JC. Nongynecologic somatic pathology in women with chronic pelvic pain and negative laparoscopy. J Reprod Med. 1991;36:253–259
  86. Walling MK, Reiter RC, O’Hara MW, Milburn AK, Lilly G, Vincent SD. Abuse history and chronic pain in women (I. Prevalences of sexual abuse and physical abuse). Obstet Gynecol. 1994;84:193–199
  87. Lampe A, Solder E, Ennemoser A, Schubert C, Rumpold G, Sollner W. Chronic pelvic pain and previous sexual abuse. Obstet Gynecol. 2000;96:929–933
  88. Collett BJ, Cordle CJ, Stewart CR, Jagger C. A comparative study of women with chronic pelvic pain, chronic nonpelvic pain and those with no history of pain attending general practitioners. Br J Obstet Gynaecol. 1998;105:87–92
  89. Carlson KJ, Miller BA, Fowler FJ. The Maine Women’s Health Study (I. Outcomes of hysterectomy). Obstet Gynecol. 1994;83:556–565
  90. Kjerulff KH, Rhodes JC, Langenberg PW, Harvey LA. Patient satisfaction with results of hysterectomy. Am J Obstet Gynecol. 2002;183:1440–1447

PII: S0015-0282(02)04216-4

Fertility and Sterility
Volume 78, Issue 5 , Pages 961-972 , November 2002

Article Tools

* Image Usage & Resolution